No corticosteroids. Anticoagulants only for severe cases.
In a cohort of relatively young patients (mean age 43,6 years, standard deviation 15.6 years), the use of antihypertensive drugs was the only independent strong predictor of poor outcomes. The age was a weak independent predictor of poor outcomes .
Tag: corticosteroids
Which of the statements on COVID-19 therapies are correct? A Test.
Given Italy’s catastrophic COVID-19 mortality rates, it is informative to take a look at the treatment option used by the Italian medical doctors.
Corticosteroid administration depletes lymphocytes and increases neutrophils in peripheral circulation.
Administration of exogenous corticosteroids to COVID-19 patients should, therefore, further increase neutrophils to leukocytes ratio (NLR). If higher NLR is associated with poor outcomes in COVID-19, administration of corticosteroids would seem counterproductive. Are steroids used appropriately in the treatment of COVID-19?
High doses of corticosteroid methylprednisolone for 1–2 days early in the course of acute respiratory distress syndrome (ARDS) may be harmful.
As of April 6, 2020, the average COVID-19 mortality rate in a selection of European and other developed countries is staggering 10%. An explanation is needed for such abysmally poor results of the medical treatment of COVID-19. One possible explanation is an inappropriate use of corticosteroids.